With 0.38 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.71 million shares. During the session, the Insurance – Life company that operates in wider Financial sector, reached to the highest price of $39.965 whereas the lowest price it dropped to was $39.55. The 52-week range on CNO shows that it touched its highest point at $40.29 and its lowest point at $24.92 during that stretch. It currently has a 1-year price target of $39.00. With its current market cap of 4.17 billion, CNO has annualized dividend of $0.62 while the current yield stands at 1.55%. Beta for the stock currently stands at 1.03.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CNO was up-trending over the past week, with a rise of 2.46%, but this was up by 14.59% over a month. Three-month performance surged to 17.94% while six-month performance rose 40.43%. The stock gained 53.44% in the past year, while it has gained 43.05% so far this year. A look at the trailing 12-month EPS for CNO yields 2.48 with Next year EPS estimates of 3.74. For the next quarter, that number is 1.06. This implies an EPS growth rate of 19.51% for this year and 1.16% for next year.
Float and Shares Shorts:
At present, 109.36 million CNO shares are outstanding with a float of 100.35 million shares on hand for trading. On 2024-10-31, short shares totaled 1.94 million, which was 188.0 higher than short shares on 1727654400. In addition to Mr. Gary Chandru Bhojwani as the firm’s CEO & Director, Mr. Paul Harrington McDonough serves as its CFO & Executive VP.
Institutional Ownership:
Through their ownership of 0.96694 of CNO’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CNO since 3 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With CNO analysts setting a high price target of 42.0 and a low target of 35.0, the average target price over the next 12 months is 38.6. Based on these targets, CNO could surge 5.24% to reach the target high and fall by -12.3% to reach the target low. Reaching the average price target will result in a decline of -3.28% from current levels.
Analysts have provided yearly estimates in a range of $3.71266 being high and $3.66316 being low. For CNO, this leads to a yearly average estimate of $3.69286. The surprise factor in the prior quarter was $0.7. Based on analyst estimates, the high estimate for the next quarter is $0.84 and the low estimate is $0.77. The average estimate for the next quarter is thus $0.8.
